Mark Toshner

Royal Papworth Hospital

Papworth Everard

Cambridge , England CB23 3RE

United Kingdom

University of Cambridge - Heart and Lung Research Institute

Cambridge

United Kingdom

SCHOLARLY PAPERS

4

DOWNLOADS
Rank 502

SSRN RANKINGS

Top 502

in Total Papers Downloads

62,738

SSRN CITATIONS

3

CROSSREF CITATIONS

2

Scholarly Papers (4)

1.

Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine

Number of pages: 37 Posted: 01 Feb 2021
University of Oxford - Oxford Vaccine Group, University of Siena - Institute of Global Health, University of the Witwatersrand - Vaccines and Infectious Diseases Analytics Research Unit, Federal University of Sao Paulo, University of Oxford - The Jenner Institute, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - The Jenner Institute, University of the Witwatersrand, Soweto Clinical Trials Centre, Soweto Clinical Trials Centre, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of the Witwatersrand - Vaccines and Infectious Diseases Analytics Research Unit, University of Oxford - The Jenner Institute, University of Oxford - Centre for Vaccinology and Tropical Medicine, Liverpool School of Tropical Medicine - Department of Clinical Sciences, University of the Witwatersrand - South African Medical Research Council Vaccines and Infectious Diseases Analytical Research Unit, University of Sheffield - Department of Infection, Immunity and Cardiovascular Disease, University of Cape Town (UCT) - Centre for Lung Infection and Immunity, University of Oxford - Jenner Institute, Newcastle upon Tyne Hospitals NHS Foundation Trust - Department of Infection and Tropical Medicine, University of Oxford - Oxford Vaccine Group, University of Oxford - The Jenner Institute, University of Oxford - The Jenner Institute, Wits Reproductive Health & HIV Institute (WRHI), University of Southampton - NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University of Oxford - Oxford Vaccine Group, University of Liverpool - School of Tropical Medicine, University of Bristol - Bristol Vaccine Centre, St George’s University London - St George’s Vaccine Institute, University College London - Department of Infection, University of Oxford - Clinical BioManufacturing Facility, University Hospitals Birmingham NHS Foundation Trust, University of Oxford - Oxford Vaccine Group, University of the Witwatersrand - South African Medical Research Council, Liverpool School of Tropical Medicine - Department of Clinical Sciences, AstraZeneca Pharmaceuticals, University of the Witwatersrand - South African Medical Research Council, University of Oxford - The Jenner Institute, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of the Witwatersrand - South African Medical Research Council, University of the Witwatersrand - South African Medical Research Council, University Hospitals Bristol - University Hospitals Bristol and Weston NHS Foundation Trust, NIHR UCLH Clinical Research Facility, Hull University Teaching Hospitals NHS Trust, University of Oxford - Centre for Vaccinology and Tropical Medicine, AstraZeneca Pharmaceuticals, Braziland Hospital São Rafael - Escola Bahiana de Medicina e Saúde Pública, Universidade Federal do Rio Grande do Norte (UFRN), University of Oxford - The Jenner Institute, London Northwest University Healthcare, University of Oxford - Oxford Vaccine Group, University of the Witwatersrand - Perinatal HIV Research Unit, Setshaba Research Centre, University of Oxford - Oxford Vaccine Group, Hospital Quinta D'OR, University of Oxford - Oxford Vaccine Group, Imperial College London - Department of Infectious Disease, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, Hospital Universitário de Santa Maria, University of Glasgow - College of Medical, Veterinary & Life Sciences, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Centre for Vaccinology and Tropical Medicine, Universidade Federal do Rio Grande do Sul, Western General Hospital - Clinical Infection Research Group, MRC-University of Glasgow Centre for Virus Research, University of Cambridge - Department of Medicine, Royal Papworth HospitalUniversity of Cambridge - Heart and Lung Research Institute, Nottingham University Hospitals NHS Trust, AstraZeneca Biopharmaceuticals, AstraZeneca Pharmaceuticals, AstraZeneca Pharmaceuticals, Anuerin Bevan University Health Board, University of Oxford - The Jenner Institute, University of Oxford - The Jenner Institute, University of Oxford - Chinese Academy of Medical Science Oxford Institute (COI), University of Oxford - Oxford Vaccine Group and Independent
Downloads 52,167 (40)
Citation 3

Abstract:

Loading...

2.

Efficacy of ChAdOx1 nCoV-19 (AZD1222) Vaccine Against SARS-CoV-2 VOC 202012/01 (B.1.1.7)

Number of pages: 40 Posted: 04 Feb 2021
University of Oxford - Oxford Vaccine Group, University of Oxford - Big Data Institute, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Cambridge, University of Oxford - The Jenner Institute, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Cambridge - Department of Medicine, University of Oxford - Big Data Institute, University of Oxford - The Jenner Institute, Public Health England - National Infection Service, University of Oxford - Centre for Vaccinology and Tropical Medicine, Liverpool School of Tropical Medicine - Department of Clinical Sciences, UK Biocentre, University of Sheffield - Department of Infection, Immunity and Cardiovascular Disease, University of Oxford - Oxford Vaccine Group, University of Oxford - Jenner Institute, Newcastle upon Tyne Hospitals NHS Foundation Trust - Department of Infection and Tropical Medicine, University of Oxford - The Jenner Institute, University of Oxford - The Jenner Institute, University of Southampton - NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University of Liverpool - School of Tropical Medicine, University of Oxford - Oxford Vaccine Group, University of Bristol - Bristol Vaccine Centre, University of Oxford - The Jenner Institute, University of Oxford - Jenner Institute, St George’s University London - St George’s Vaccine Institute, University College London - Department of Infection, University of Oxford - Clinical BioManufacturing Facility, University Hospitals Birmingham NHS Foundation Trust, University of Oxford - Oxford Vaccine Group, Public Health England - National Infection Service, University of London - Institute of Infection and Immunity, Queen Elizabeth University Hospital, Liverpool School of Tropical Medicine - Department of Clinical Sciences, University of Oxford - The Jenner Institute, University of Oxford - Centre for Vaccinology and Tropical Medicine, University Hospitals Bristol - University Hospitals Bristol and Weston NHS Foundation Trust, NIHR UCLH Clinical Research Facility, Hull University Teaching Hospitals NHS Trust, Genomics England, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - The Jenner Institute, London Northwest University Healthcare, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, Imperial College London - Department of Infectious Disease, University of Oxford - Oxford Vaccine Group, University of Glasgow - College of Medical, Veterinary & Life Sciences, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Centre for Vaccinology and Tropical Medicine, Western General Hospital - Clinical Infection Research Group, MRC-University of Glasgow Centre for Virus Research, Royal Papworth HospitalUniversity of Cambridge - Heart and Lung Research Institute, Nottingham University Hospitals NHS Trust, AstraZeneca Biopharmaceuticals, AstraZeneca Pharmaceuticals, Anuerin Bevan University Health Board, University of Oxford - The Jenner Institute, University of Oxford - The Jenner Institute, University of Oxford - Chinese Academy of Medical Science Oxford Institute (COI), University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, Independent and Independent
Downloads 10,494 (806)
Citation 26

Abstract:

Loading...

3.

Vascular Thrombosis in Severe COVID-19: A Multicenter Study

Number of pages: 29 Posted: 24 Sep 2020
NHS Foundation Trust - Department of Radiology, Royal Papworth Hospital, Guy's and St Thomas NHS Foundation Trust, University Hospitals of Leicester NHS Trust, Royal Papworth Hospital, Royal Papworth Hospital, Royal Papworth HospitalUniversity of Cambridge - Heart and Lung Research Institute, Guy's and St Thomas NHS Foundation Trust, University Hospitals of Leicester NHS Trust, University Hospitals of Leicester NHS Trust, University Hospitals of Leicester NHS Trust, Royal Papworth Hospital, Royal Papworth Hospital, Center for Medical Image Computing, University College London, UCL Respiratory, University College London, Guy's and St Thomas NHS Foundation Trust and Royal Papworth Hospital
Downloads 44 (644,528)

Abstract:

Loading...

Embolism and Thrombosis; COVID-19; Tomography, X-Ray Computed, Extracorporeal Membrane Oxygenation

4.

Early Immune Pathology and Persistent Dysregulation Characterise Severe COVID-19

Number of pages: 105 Posted: 29 Dec 2020
University of Cambridge - Department of Medicine, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Department of Medicine, University of Cambridge - MRC Biostatistics Unit, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Department of Medicine, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Department of Medicine, NIHR Cambridge Clinical Research Facility, University of Cambridge - Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), NIHR Cambridge Clinic Research Facility - Addenbrooke's Hospital, University of Cambridge - Division of Virology, Cambridge Institute of Therapeutic Immunology & Infectious Disease, Addenbrooke's Hospital - Division of Virology, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, NIHR Cambridge Biomedical Research Centre - NIHR BioResource, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, Murdoch University - The Centre for Computational and Systems Medicine, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - MRC Biostatistics Unit, NIHR Cambridge Clinic Research Facility - Addenbrooke's Hospital, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, Hycult Biotech - R&D Department, Cambridge University Hospitals NHS Foundation Trust, Independent, Royal Papworth HospitalUniversity of Cambridge - Heart and Lung Research Institute, University Hospital Basel - Immunobiology Laboratory, University of Cambridge - Department of Medicine, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease and University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease
Downloads 33 (713,349)

Abstract:

Loading...